@article{9bc642af51a04feaa2f2d3200c1414c8,
title = "Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma (Oncogene, (2022), 41, 21, (2973-2983), 10.1038/s41388-022-02305-x)",
abstract = "Following the publication of this article a number of copy editing omissions were noted. These have now been corrected.",
author = "Patience Odeniyide and Yohe, \{Marielle E.\} and Kai Pollard and Vaseva, \{Angelina V.\} and Ana Calizo and Lindy Zhang and Rodriguez, \{Fausto J.\} and Gross, \{John M.\} and Allen, \{Amy N.\} and Xiaolin Wan and Romel Somwar and Schreck, \{Karisa C.\} and Linda Kessler and Jiawan Wang and Pratilas, \{Christine A.\}",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = may,
day = "20",
doi = "10.1038/s41388-022-02342-6",
language = "English (US)",
volume = "41",
pages = "3037",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Springer Nature",
number = "21",
}